In animal studies that we've done, Drucker says, we demonstrated that GLP-1 protects the heart and reduces atherosclerosis and protects the kidney and improves the health of the liver. In November 2024, a GLP-1 receptor agonist, a medication that mimics the action of the GLP-1 hormone, was approved by Health Canada for cardiovascular disease in overweight people
Abstract Background With the prevalence of obesity rising in the US, medical management is of increasing importance
The FDA temporarily allowed compounders to make some versions of the drugs which telehealth providers offered patients at much lower prices ($150-$400 per month)
Glutathione and Sun Damage Glutathione is one of our bodys most powerful antioxidants, responsible for neutralizing free radicals and detoxifying skin-damaging compounds
Once you've discovered your tretinoin skin-care routine, you'll never look back
Do not stop Ozempic without consulting your GP or diabetes specialist, as this may compromise glycaemic control